Non-Alcoholic Steatohepatitis Market Forecasts, Size, Share, Regional Outlook 20

Posted by akshayparmar on November 9th, 2017

Non-Alcoholic Steatohepatitis Market – (Drug Type – Obeticholic Acid, Aramchol, Saroglitazar and Elafibranors): Market Growth, Future Prospects and Competitive Analysis, 2017-2025, the market was valued at US$ 729.0 Mn in 2016, and is expected to reach US$ 20,676.0 Mn by 2025, expanding at a CAGR of 46.1% from 2017 to 2025.

Browse Full Report Visit - http://www.acutemarketreports.com/report/non-alcoholic-steatohepatitis-market

Market Insights

Nonalcoholic Steatohepatitis (NASH) is the progressive form of Nonalcoholic Fatty Liver Disease (NAFLD), wherein excessive fat deposition causes inflammation and damage to the liver, eventually leading to cirrhosis and increasing risk of liver failure and hepatocellular carcinoma in some cases. NASH affects around 2-5% of Americans and is considered to be one of the foremost causes of liver transplantation. Currently management of NASH includes lifestyle changes such as healthy diet, weight reduction and physical activity. Despite of growing treatment need there are no approved therapeutic for NASH. Some drugs are prescribed off-label such as Metformin which is used in type-2 diabetes and NASH.

Market Competition Assessment:

The non-alcoholic steatohepatitis market has major pharmaceutical companies such as Gilead Sciences, Novo Nordisk, and Bristol-Myers Squibb developing drugs for NASH or its consequences, with Allergan the latest to enter the space. Allergan acquired Tobira Therapeutics Inc. and Akarna Therapeutics Ltd. in the second half of 2016. These acquisitions provide Allergan a readymade pipeline for the potentially lucrative NASH market.

Key Market Movements:

- Lucrative pipeline for NASH market with more than 20 molecules undergoing clinical trials would boost the demand for NASH market.
- Alarming rise in the diabetes and obesity prevalence would act as a driving factor for the growth of the NASH market.

Chapter 1 Preface 
1.1 Report Description 
1.1.1 Purpose of the Report 
1.1.2 Target Audience 
1.1.3 USP and Key Offerings 
1.2 Research Scope 

Chapter 2 Executive Summary 
2.1 Non-Alcoholic Steatohepatitis Market Portraiture 
2.2 Non-Alcoholic Steatohepatitis Market, by Drug Type, 2016 (US$ Mn) 
2.3 Non-Alcoholic Steatohepatitis Market, by Geography, 2016 (Value %)

Chapter 3 Global Non-Alcoholic Steatohepatitis Market Analysis 
3.1 Global Non-Alcoholic Steatohepatitis Market Overview 
3.2 Market Dynamics 
3.2.1 Market Drivers 
3.2.1.1 Lucrative Pipeline for NASH Therapeutics 
3.2.1.2 Alarming rise in the diabetic and Obese Population Globally
3.2.2 Challenges 

About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us :

Name : Chris Paul

ACUTE MARKET REPORTS

Designation : Global Sales Manager

Toll Free(US/CANADA): +1-855-455-8662

Email : sales@acutemarketreports.com

Website :http://www.acutemarketreports.com